DE60118913T2 - Transgenes tiermodell für neurodegenerative erkrankungen - Google Patents

Transgenes tiermodell für neurodegenerative erkrankungen Download PDF

Info

Publication number
DE60118913T2
DE60118913T2 DE60118913T DE60118913T DE60118913T2 DE 60118913 T2 DE60118913 T2 DE 60118913T2 DE 60118913 T DE60118913 T DE 60118913T DE 60118913 T DE60118913 T DE 60118913T DE 60118913 T2 DE60118913 T2 DE 60118913T2
Authority
DE
Germany
Prior art keywords
replaced
transgene
residue
promoter
app
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60118913T
Other languages
German (de)
English (en)
Other versions
DE60118913D1 (de
Inventor
H. Peter Toronto ST. GEORGE-HYSLOP
E. Paul Toronto FRASER
David Etobicoke WESTAWAY
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Toronto
Original Assignee
University of Toronto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Toronto filed Critical University of Toronto
Application granted granted Critical
Publication of DE60118913D1 publication Critical patent/DE60118913D1/de
Publication of DE60118913T2 publication Critical patent/DE60118913T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0306—Animal model for genetic diseases
    • A01K2267/0312—Animal model for Alzheimer's disease
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0306—Animal model for genetic diseases
    • A01K2267/0318—Animal model for neurodegenerative disease, e.g. non- Alzheimer's

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Environmental Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Animal Husbandry (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Eye Examination Apparatus (AREA)
DE60118913T 2000-06-20 2001-06-19 Transgenes tiermodell für neurodegenerative erkrankungen Expired - Lifetime DE60118913T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21253400P 2000-06-20 2000-06-20
US212534P 2000-06-20
PCT/CA2001/000900 WO2001097607A2 (en) 2000-06-20 2001-06-19 Transgenic animal model of neurodegenerative disorders

Publications (2)

Publication Number Publication Date
DE60118913D1 DE60118913D1 (de) 2006-05-24
DE60118913T2 true DE60118913T2 (de) 2007-01-25

Family

ID=22791418

Family Applications (2)

Application Number Title Priority Date Filing Date
DE60118913T Expired - Lifetime DE60118913T2 (de) 2000-06-20 2001-06-19 Transgenes tiermodell für neurodegenerative erkrankungen
DE60144164T Expired - Lifetime DE60144164D1 (de) 2000-06-20 2001-06-19 Transgenes Tiermodel für neurodegenerative Krankheiten

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE60144164T Expired - Lifetime DE60144164D1 (de) 2000-06-20 2001-06-19 Transgenes Tiermodel für neurodegenerative Krankheiten

Country Status (13)

Country Link
EP (3) EP1292187B1 (enExample)
JP (3) JP4938956B2 (enExample)
AT (2) ATE323408T1 (enExample)
AU (1) AU2001270377A1 (enExample)
CA (1) CA2407847C (enExample)
CY (1) CY1105122T1 (enExample)
DE (2) DE60118913T2 (enExample)
DK (1) DK1292187T3 (enExample)
ES (1) ES2262662T3 (enExample)
MX (1) MXPA02011516A (enExample)
PT (1) PT1292187E (enExample)
SI (1) SI1292187T1 (enExample)
WO (1) WO2001097607A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ536064A (en) 2002-04-19 2008-06-30 Univ Toronto Immunological methods and compositions for the treatment of alzheimer's disease
US7544855B2 (en) * 2004-04-23 2009-06-09 Buck Institute Transgenic mouse whose genome comprises an APP having a mutation at amino acid 664
JP4590638B2 (ja) * 2006-03-20 2010-12-01 国立大学法人鳥取大学 家族性筋萎縮性側索硬化症（ｆａｌｓ）発症するトランスジェニックマウス
CL2007002908A1 (es) 2007-10-09 2008-05-30 Univ Concepcion Procedimiento electroquimico in vitro para evaluar capacidad neurotoxica de estructuras, principios activos y/o compuestos de interes en celulas vivas y que comprende medir y cuantificar los parametros electricos en membranas expuestas a dichos agreg
US20100306868A1 (en) * 2007-11-01 2010-12-02 Bernd Bohrmann Quadruple transgenic non-human animal
US20110214195A1 (en) * 2008-11-10 2011-09-01 The Regents Of The University Of Colorado, A Body Corporate Methods For Treating Clinical Conditions Associated With Lipoprotein Lipase Activity

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69426571T2 (de) 1993-10-27 2001-08-09 Elan Pharm Inc TRANSGENE TIERE, DIE APP Allele mit der schwedischen Mutation beherbergen
JPH07132033A (ja) 1993-11-12 1995-05-23 Hoechst Japan Ltd アルツハイマー病モデルトランスジェニック動物
US5877399A (en) 1994-01-27 1999-03-02 Johns Hopkins University Transgenic mice expressing APP-Swedish mutation develop progressive neurologic disease
DE69533583T2 (de) * 1994-01-27 2005-10-06 Regents of the University of Minnesota, Southeast, Minneapolis Nicht humane, transgenische säugetiere mit sich entwickelnder neurologischer krankheit
WO1996040895A1 (en) * 1995-06-07 1996-12-19 Athena Neurosciences, Inc. Method for identifying alzheimer's disease therapeutics using transgenic animal models
US5894078A (en) 1996-02-26 1999-04-13 Advanced Bioconcept, Inc. Transgenic mouse expressing C-100 app
WO1999009150A1 (en) * 1996-08-15 1999-02-25 Bayer Corporation Method of introducing modifications into a gene
US5898094A (en) 1996-10-21 1999-04-27 University Of South Florida Transgenic mice expressing APPK670N,M671L and a mutant presenilin transgenes
TWI239847B (en) 1997-12-02 2005-09-21 Elan Pharm Inc N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease

Also Published As

Publication number Publication date
DE60118913D1 (de) 2006-05-24
PT1292187E (pt) 2006-07-31
JP2003535605A (ja) 2003-12-02
WO2001097607A3 (en) 2002-12-12
EP1728423A3 (en) 2007-02-28
ATE499832T1 (de) 2011-03-15
CA2407847C (en) 2013-08-27
DK1292187T3 (da) 2006-08-21
EP2263453B1 (en) 2018-06-13
EP1292187A2 (en) 2003-03-19
ATE323408T1 (de) 2006-05-15
MXPA02011516A (es) 2005-07-01
DE60144164D1 (de) 2011-04-14
EP1728423A2 (en) 2006-12-06
WO2001097607A2 (en) 2001-12-27
ES2262662T3 (es) 2006-12-01
CY1105122T1 (el) 2010-03-03
CA2407847A1 (en) 2001-12-27
SI1292187T1 (sl) 2006-10-31
JP2009178162A (ja) 2009-08-13
JP5070236B2 (ja) 2012-11-07
JP2011172600A (ja) 2011-09-08
AU2001270377A1 (en) 2002-01-02
EP2263453A1 (en) 2010-12-22
JP4938956B2 (ja) 2012-05-23
EP1728423B1 (en) 2011-03-02
EP1292187B1 (en) 2006-04-19

Similar Documents

Publication Publication Date Title
Philipson et al. Animal models of amyloid‐β‐related pathologies in Alzheimer’s disease
DE69533583T2 (de) Nicht humane, transgenische säugetiere mit sich entwickelnder neurologischer krankheit
DE69426571T2 (de) TRANSGENE TIERE, DIE APP Allele mit der schwedischen Mutation beherbergen
US6717031B2 (en) Method for selecting a transgenic mouse model of alzheimer's disease
US5877399A (en) Transgenic mice expressing APP-Swedish mutation develop progressive neurologic disease
US7393994B2 (en) Transgenic mouse model for neurodegenerative diseases
WO1997048792A9 (en) Transgenic non-human mammals with progressive neurologic disease
Dodart et al. Overview on rodent models of Alzheimer's disease
US7479579B2 (en) Triple transgenic mouse model of Alzheimer's disease
JP5070236B2 (ja) 神経変性性障害のトランスジェニック動物モデル
US20120180143A1 (en) Transgenic animal model of neurodegenerative disorders
CA2814737C (en) Use of an a.beta.42 peptide to reduce a cognitive deficit in a subject
DE60121324T2 (de) Tiermodel für neurodegenerative erkrankungen
Koch Animal models of neuropsychiatric diseases
HK1152200A (en) Transgenic animal model of neurodegenerative disorders
Gärtner et al. Animal Models of Alzheimer's Disease
Seidner Modeling clinically heterogeneous Alzheimer's disease-linked Presenilin mutations with transgenic Drosophila
Garcia An Assessment of Cognitive and Sensorimotor Deficits Associated with APPsw and P301L Mouse Models of Alzheimer's Disease

Legal Events

Date Code Title Description
8364 No opposition during term of opposition